Larvol Delta - Cognition-Therapeutics-Presents-Phase-3-Plan-for-Zervimesine-CT1812-in-Alzheimers-Disease-at-Clinical-Trials-on-Alzheimers-Disease-CTAD-Conference

Elayta (zervimesine) - Cognition Therap

https://www.globenewswire.com/news-release/2025/12/01/3196911/0/en/Cognition-Therapeutics-Presents-Phase-3-Plan-for-Zervimesine-CT1812-in-Alzheimer-s-Disease-at-Clinical-Trials-on-Alzheimer-s-Disease-CTAD-Conference.html

Dec 1, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next